A Phase II, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of HEX17, a Novel Broad-Spectrum Antiviral Drug, in a Controlled Human Infection Model of Influenza Challenge. - Kitson, Geoff; Byford, Marion; Cass, Lindsey; Howat, David; Köhn, Brigitte; Bisquera, Alessandra; Catchpole, Andrew; Noulin, Nicolas; Thomson, Douglas (Infectious Diseases & Therapy, 2025)